Skip to main content
. 2017 Nov 27;8(65):109596–109608. doi: 10.18632/oncotarget.22741

Table 1. The primers.

Primers Forward Reverse
TRIB2 CTTTTGCCTGTCTGCTCATAGT ATAGCTTCGCTCAAAGAACACA
CEBPA CAAGGCCAAGAAGTCGGTGGACAA TCATTGTCACTGGTCAGCTCCAGC
ABCG2 ACGAACGGATTAACAGGGTCA CTCCAGACACACCACGGAT
ALDH1A1 AACTCCTCTCACTGCTCTCCACG GTCACCCTCTTCAGATTGCTTTTCC
THY1 (CD90) TCAGGAAATGGCTTTTCCCA TCCTCAATGAGATGCCATAAGCT
kit (CD117) TACTCATGGTCGGATCACAAA CCACTTCACAGGTAGTCGAGC
PROM1 (CD133) AGTGGATCGAGTTCTCTATCAGTG CAGTAGCTTTTCCTATGCCAAACC
PLAUR (CD78) CCACTCAGAGAAGACCAACAGG GGTAACGGCTTCGGGAATAGG
CD47 GGCAATGACGAAGGAGGTTA ATCCGGTGGTATGGATGAGA
GAPDH GGAGCGAGATCCCTCCAAAAT GGCTGTTGTCATACTTCTCATGG